Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones.
Abstract: Current methods in medical image semantic segmentation often rely on simple skip connections within U-shaped network structures. These approaches fail to bridge the semantic gap between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback